Order Article Reprints

Moraes FCAd, de Oliveira Almeida G, Alves VFC, Priantti JN, Gomes GdC, Carnevalli SVB, Madeira T, Vilbert M, Stecca C, Figueroa Magalhães MC, et al. Cyclin-Dependent Kinase 4/6 Inhibitors Plus Endocrine Therapy versus Endocrine Therapy Alone for HR-Positive, HER-2-Negative Early Breast Cancer: Meta-Analysis of Phase III Randomized Clinical Trials. Journal of Personalized Medicine. 2024; 14(5):464. https://doi.org/10.3390/jpm14050464

Moraes, Francisco Cezar Aquino de, Gustavo de Oliveira Almeida, Vinícius Freire Costa Alves, Jonathan N. Priantti, Giovanna da Conceição Gomes, Sarah Vitória Bristot Carnevalli, Thiago Madeira, Maysa Vilbert, Carlos Stecca, Maria Cristina Figueroa Magalhães, and et al. 2024. "Cyclin-Dependent Kinase 4/6 Inhibitors Plus Endocrine Therapy versus Endocrine Therapy Alone for HR-Positive, HER-2-Negative Early Breast Cancer: Meta-Analysis of Phase III Randomized Clinical Trials" Journal of Personalized Medicine 14, no. 5: 464. https://doi.org/10.3390/jpm14050464

Moraes, F. C. A. d., de Oliveira Almeida, G., Alves, V. F. C., Priantti, J. N., Gomes, G. d. C., Carnevalli, S. V. B., Madeira, T., Vilbert, M., Stecca, C., Figueroa Magalhães, M. C., Fernandes, M. R., & dos Santos, N. P. C. (2024). Cyclin-Dependent Kinase 4/6 Inhibitors Plus Endocrine Therapy versus Endocrine Therapy Alone for HR-Positive, HER-2-Negative Early Breast Cancer: Meta-Analysis of Phase III Randomized Clinical Trials. Journal of Personalized Medicine, 14(5), 464. https://doi.org/10.3390/jpm14050464